 | Dr. Christopher Cooper Dean College of Medicine and Life Sciences University of Toledo Dr. Cooper will provide the keynote presentation at this year's 2016 EPIC Toledo Leadership Summit titled "The Authentic You." |
Dr. Christopher Cooper graduated Magna cum laude from Wittenberg University with a Bachelor’s degree in Biology as well as obtaining several other scholarships and awards. He was valedictorian and achieved Alpha Omega Alpha at the University of Cincinnati College of Medicine where he earned his medical degree. After completing his Cardiology fellowship at The Brigham and Women’s Hospital and Harvard Medical School, including an intensive course in Clinical Effectiveness covering biostatistics, epidemiology, decision analysis and health policy research, Dr. Cooper joined the Cardiovascular Medicine Division at the University of Toledo Medical Center. He was a finalist for the Samuel A. Levine Young Clinical Investigator Award from the American Heart Association Council on Clinical Cardiology. Dr. Cooper served as Professor and Chief of the Cardiovascular Medicine Division at UTMC from 2002 until July, 2012 when he was named Interim Chairman of the Department of Medicine. Following an extensive national search, Dr. Cooper was named Chairman of the Department of Medicine in July, 2013. In August 2014, Dr. Cooper was appointed to the position of Executive Vice President for Clinical Affairs and Dean of the College of Medicine and Life Sciences at the University of Toledo. He founded the Cardiovascular Medicine Research Program and the Heart and Vascular Center at the institution.
Dr. Cooper is a member of several Regional and National societies. He is the President of the Ohio Chapter of the American College of Cardiology and resides on the Board of Governors of the National American College of Cardiology. Other honors include “Best Doctors in America” issued by Best Doctors in America, Midwest and “America’s Top Doctors” issued by Castle Connolly. Among service to committees, clinics, and administration, Dr. Cooper also mentors medical and Ph.D. students in research. Currently he serves as Principal Investigator, and director for the Clinical Coordinating Center of the NIH funded CORAL Trial with grant funding of over $2.3M. This study is an international, multi-center pivotal clinical trial that compares medical therapy alone against medical therapy with stenting for renal artery stenosis. Dr. Cooper serves as a reviewer for a number of cardiology, vascular, and nephrology journals as well as on the editorial staff of several journals (Vascular Medicine and Vascular Disease Management). He has 61 publications in peer-reviewed journals and 6 book chapters. His research interest focuses on ischemic renal disease. Clinically he is an interventional cardiologist that helped pioneer the transradial method for cardiac catheterization, has performed and published extensively on renal artery stenting, and has considerable experience in the management of resistant hypertension.
Dr. Cooper is a member of several Regional and National societies. He is the President of the Ohio Chapter of the American College of Cardiology and resides on the Board of Governors of the National American College of Cardiology. Other honors include “Best Doctors in America” issued by Best Doctors in America, Midwest and “America’s Top Doctors” issued by Castle Connolly. Among service to committees, clinics, and administration, Dr. Cooper also mentors medical and Ph.D. students in research. Currently he serves as Principal Investigator, and director for the Clinical Coordinating Center of the NIH funded CORAL Trial with grant funding of over $2.3M. This study is an international, multi-center pivotal clinical trial that compares medical therapy alone against medical therapy with stenting for renal artery stenosis. Dr. Cooper serves as a reviewer for a number of cardiology, vascular, and nephrology journals as well as on the editorial staff of several journals (Vascular Medicine and Vascular Disease Management). He has 61 publications in peer-reviewed journals and 6 book chapters. His research interest focuses on ischemic renal disease. Clinically he is an interventional cardiologist that helped pioneer the transradial method for cardiac catheterization, has performed and published extensively on renal artery stenting, and has considerable experience in the management of resistant hypertension.
2016 EPIC Toledo Leadership Summit
The EPIC Toledo Leadership Summit is the premier event for young professionals in the Toledo Region and brings together over 350 young professionals and community leaders. The event focuses on community building and career enhancement. This will be an opportunity for young professionals to learn about themselves and become outstanding leaders for your company and our community.
Discover more and register on the Event Website.
Discover more and register on the Event Website.
RSS Feed
